Please assess the completion status of the following clinical trial:

Trial Title: Safety and Feasibility of Electrochemotherapy in Unresectable Colorectal Adenocarninoma Liver Metastases

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female patients \> 18 years of age~* Histological confirmed colorectal adenocarcinoma~* Histological or clinically confirmed metastatic colorectal adenocarcinoma lesions (liver lesions only are considered as metastatic disease) and not resecable.~* A single liver lesion may not exceed 3 cm~* Liver lesions must not have a depth greater than 2 cm from hepatic surface (Glisson Capsule) (measured clinically if possible otherwise on the basis of CT/ultrasound examination)~* A life expectancy of at least 6 months.~* Patients with a ECOG performance status \< 2~* Signed Informed Consent~* Patient must be mentally capable of understanding the information given.~* Patient must give informed consent.~Exclusion Criteria:~* Age less than 18 years.~* Patient pregnant or lactating (no contraceptive method is contraindicated, a pregnancy test will be administered to all women of childbearing age)~* Life-threatening infection and/or heart failure and/or liver failure and/or other severe systemic pathologies that preclude laparotomy~* Strumental analysis confirmed ascites.~* Impaired kidney function.~* Significant reduction in respiratory function.~* Allergic reaction to bleomycin.~* Coagulation disturbances~* Patients with exclusion criteria for diagnostic MRI 3Tesla (with pace-makers and all those metal devices that are not compatible with 3T).

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- electrochemotherapy (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).